About Celero Systems
Celero Systems is a Healthcare company based in Lincoln (United States) founded in 2017 by Giovanni Traverso. An ingestible device for detecting opioid overdoses is developed. Its chief executive, as recorded, is Benjamin Pless. Celero Systems offers products and services including Digital Health Platform, Sleep Apnea Diagnostics, and Opioid Risk Management. Its focus areas include Life Sciences, Toxicology, Medical Devices and Drug Testing Device. Its competitors include Pocket Naloxone, Labb and Oral Cube; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 2017 and based in Lincoln, United States, Celero Systems operates in the medical device sector. An ingestible system is developed using proprietary technologies to detect opioid overdoses and deliver autonomous interventions. Mortality and injury from overdoses are addressed through timely responses provided by the device. Operations focus on integrating therapies for life-saving outcomes in the health technology field.
- Headquarters Lincoln, United States
- Founders Giovanni Traverso
- SectorsHealthcare
- Email••••••••
- Website celerosystems.com
- Social LinkedIn
Products & Services of Celero Systems
Celero Systems offers a comprehensive portfolio of products and services, including Digital Health Platform, Sleep Apnea Diagnostics, and Opioid Risk Management.
Platform for monitoring and diagnosing sleep apnea remotely.
Tool for detecting sleep apnea through vital sign tracking.
System for managing opioid risks via data analysis.
People of Celero Systems
9 people are tracked at Celero Systems (6 in leadership, 3 in board & advisors).
| Name | Role | Group |
|---|---|---|
Giovanni Traverso | Co-Founder | Leadership |
Benjamin Pless | CEO | Leadership |
Dan Bacher | VP, R&D | Leadership |
Craig Patterson | CFO & VP, Business Development | Leadership |
Ben Pless | CEO & Founder | Leadership |
Shannon Schuetz | Senior Director, Operations | Leadership |
Robert Langer | Advisor | Board & advisors |
Jeremy Ruskin | Advisor | Board & advisors |
Ali Rezai | Advisor | Board & advisors |
Complete people profiles for Celero Systems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Celero Systems
Celero Systems has 3 listed competitors in our database, 1 of them funded. They include Pocket Naloxone, Labb and Oral Cube.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pocketnaloxone.com | 2019 | Bethesda, United States | $6.16M | 3 | FDA-approved devices for opioid overdose management are developed. | |
| labb.com | 2017 | Portsmouth, United States | Mobile app for efficient drug testing and rapid results via various specimen types. | |||
| oralcube.com | 2014 | Salt Lake, United States | Provides comprehensive drug and alcohol testing devices for healthcare providers and clinics. |
Detailed competitors of Celero Systems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Celero Systems
The website of Celero Systems (celerosystems.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 266.9% vs previous month
Top companies in Toxicology
3 companies that operate in the same segment as Celero Systems (Toxicology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic solutions for food allergies are developed via antibody platforms. | 2019 | San Francisco, California, United States | USD 75 M | |||
Therapeutics for substance use disorders, including opioid-related conditions, are developed. | 2020 | Oakland, California, United States | USD 70 M | |||
Drug delivery solutions via single-walled carbon nanotubes are offered. | 2008 | Houston, Texas, United States | USD 2.5 M | USD 5.07 M | 9 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Celero Systems
Celero Systems was founded in 2017.
Celero Systems is headquartered in Lincoln, United States. It is registered at Lincoln, Nebraska, United States.
Benjamin Pless is the CEO of Celero Systems, as recorded in our data.
Founded in 2017 and based in Lincoln, United States, Celero Systems operates in the medical device sector. An ingestible system is developed using proprietary technologies to detect opioid overdoses and deliver autonomous interventions. Mortality and injury from overdoses are addressed through timely responses provided by the device. Operations focus on integrating therapies for life-saving outcomes in the health technology field.
Celero Systems's top competitors include Pocket Naloxone, Labb and Oral Cube.
Celero Systems offers Digital Health Platform, Sleep Apnea Diagnostics, and Opioid Risk Management.